logo_new@0,75x

logo_new@0,75x

Glycotest’s Patent Portfolio Covering Detection of Serious Liver Disease Expanded by Grant of European Patent

January 13, 2021

-

News

-

-

Posted by glycotest

Glycotest’s Patent Portfolio Covering Detection of Serious Liver Disease Expanded by Grant of European Patent.

Leave a Comment

Your feedback is valuable for us. Your email will not be published.

Related News

Other posts that you should not miss.

Six new patents protecting Glycotest’s HCC Panel test have been issued or allowed in the United States, Europe, China, Taiwan, Japan, and Mexico.

Six new patents protecting Glycotest’s HCC Panel test have been issued or allowed in the United States, Europe, China, Taiwan, Japan, and Mexico

March 1, 2023

-

Posted by glycotest

Glycotest Third Party Fundraise

Glycotest Third Party Fundraise

May 3, 2023

-

Posted by glycotest

More than 50 Glycotest Fucosylated Biomarkers Protected through Grant of New US Patent.

November 3, 2020

-

Posted by glycotest

GET IN TOUCH

Give Us A Call

+1 484-431-3483

Send Us A Message

info@glycotest.com

Copyright© All Rights Reserved

Website Designed & Developed by Jason and Company

Glycotest’s Patent Portfolio Covering Detection of Serious Liver Disease Expanded by Grant of European Patent | Glycotest Diagnostics